Education
About Us
Working with TipRanks
Follow Us
Vitrolife AB (SE:VITR)
:VITR
Earnings Data
Report Date
Apr 23, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.82Last Year’s EPS
0.74Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call reported healthy operational momentum in key growth areas — notably Americas (9% organic growth, Technologies +40% in Q4) and APAC (10% organic growth) — and outlined clear strategic steps (Genetic Services restructuring, commercial investment, EmbryoScope penetration). However, significant FX headwinds, one‑time restructuring costs, higher OpEx and meaningful declines in margins, EBITDA, net income and operating cash flow tempered the financial outcome. The company emphasizes that many adverse effects were currency- and mix-driven and expects a return to more normal market and margin levels in 2026, while keeping leverage stable and maintaining the dividend.Company Guidance
Q4 Revenue and Organic Growth
Q4 sales of SEK 891 million with 6% organic growth in local currency excluding discontinued business; full-year sales SEK 3.5 billion with 4% organic growth in local currency excluding discontinued business (2% growth in local currencies for the full year including discontinued business).
Strong Americas Performance and Technologies Momentum
Americas Q4 sales SEK 299 million, representing 34% of Group revenue and 9% organic growth in local currency. Technologies in Americas grew ~40% in the quarter, driven by increased EmbryoScope penetration and commercial investments.
Robust APAC Finish
APAC Q4 sales SEK 259 million with 10% organic growth in local currency. Consumables grew 11% and Technologies grew 13% in APAC, driven by targeted disposable device campaign and year-end budget release for capital purchases.
Consumables Share Gains in EMEA
EMEA Consumables delivered 11% growth in the quarter, outperforming market growth and delivering share gains in key focus markets (EMEA accounts for 34% of total sales).
Strategic Restructuring and Commercial Focus
Announced restructuring of the Genetic Services business (phasing out GPDx and NACE and exiting some markets) to focus on higher‑prospect tests/markets; increased commercial excellence capabilities and cross‑selling (more customers buying across Consumables, Technologies and Genetic Services); explicit push to accelerate EmbryoScope + lab control penetration.
Balance Sheet Stability and Shareholder Return
Leverage (net debt/EBITDA) ended at 0.7 (unchanged year-on-year). Proposed dividend SEK 1.10 per share, unchanged from prior year, signalling a stable capital return policy.
SE:VITR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SE:VITR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 03, 2026 | kr117.10 | kr91.90 | -21.52% |
Oct 23, 2025 | kr145.00 | kr148.00 | +2.07% |
Jul 17, 2025 | kr151.30 | kr142.00 | -6.15% |
Apr 24, 2025 | kr155.26 | kr143.44 | -7.61% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Vitrolife AB (SE:VITR) report earnings?
Vitrolife AB (SE:VITR) is schdueled to report earning on Apr 23, 2026, Before Open (Confirmed).
What is Vitrolife AB (SE:VITR) earnings time?
Vitrolife AB (SE:VITR) earnings time is at Apr 23, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Vitrolife AB stock?
The P/E ratio of Vitrolife AB is N/A.
What is SE:VITR EPS forecast?
SE:VITR EPS forecast for the fiscal quarter 2026 (Q1) is 0.82.